Creating Cell Therapy Solutions
Nature Biopharama Dealmakers Feature
Minaris' global team of experts have become a trusted partner for clinical and commercial manufacturing of cell therapies.
With more than two decades of cell-therapy manufacturing experience, including a wide range of cell types, manufacturing technologies and procedures, and regulatory expertise, we have been leading the way in the field. This includes advancing one of the first cell and gene therapies through clinical development, and being one of the first CDMOs to manufacture commercial cell therapy.
Download our feature that is seen within Nature Biopharma Dealmakers September 2021 issue to read more about our consulting, development, partnering, and how we are delivering cell-based therapies to patients globally.
Fill out the form to access the article!
